These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37824804)

  • 1. Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells.
    Wang J; Su M; Wei N; Yan H; Zhang J; Gong Y; Wu L; Suolitiken D; Pi Y; Song D; Chen L; Liu H; Yang S; Wang X; Wang Z
    Blood; 2024 Jan; 143(1):32-41. PubMed ID: 37824804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.
    Watanabe Y; Sasahara Y; Satoh M; Looi CY; Katayama S; Suzuki T; Suzuki N; Ouchi M; Horino S; Moriya K; Nanjyo Y; Onuma M; Kitazawa H; Irie M; Niizuma H; Uchiyama T; Rikiishi T; Kumaki S; Minegishi M; Wada T; Yachie A; Tsuchiya S; Kure S
    Eur J Haematol; 2013 Sep; 91(3):242-248. PubMed ID: 23734904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
    Kawamoto K; Miyoshi H; Seto M; Kimura H; Ohshima K
    Rinsho Ketsueki; 2019; 60(8):944-952. PubMed ID: 31484894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
    Xiao H; Hu B; Luo R; Hu H; Zhang J; Kuang W; Zhang R; Li L; Liu G
    Virol J; 2020 Oct; 17(1):166. PubMed ID: 33121509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development.
    Arai A
    Front Pediatr; 2019; 7():14. PubMed ID: 30805320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated guidelines for chronic active Epstein-Barr virus disease.
    Kawada JI; Ito Y; Ohshima K; Yamada M; Kataoka S; Muramatsu H; Sawada A; Wada T; Imadome KI; Arai A; Iwatsuki K; Ohga S; Kimura H;
    Int J Hematol; 2023 Nov; 118(5):568-576. PubMed ID: 37728704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
    Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
    Sakamoto Y; Mariya Y; Kubo K
    Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of detecting the EBV-DNA level in peripheral blood mononuclear cells and the EBV-infected cell type in patients with chronic active EBV infection].
    Xing Y; Song HM; Wu XY; Wang W; Wei M
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):495-500. PubMed ID: 22088177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders.
    Sawada A; Inoue M
    Front Pediatr; 2018; 6():334. PubMed ID: 30460216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
    Roliński J; Grywalska E; Pyzik A; Dzik M; Opoka-Winiarska V; Surdacka A; Maj M; Burdan F; Pirożyński M; Grabarczyk P; Starosławska E
    BMC Infect Dis; 2018 Apr; 18(1):190. PubMed ID: 29678144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic active Epstein-Barr virus infection involving gastrointestinal tract with hemophagocytic lymphohistiocytosis.
    Shen K; Shuai X; Li J; Liu J; Liu T; Niu T; Ma H
    Ann Hematol; 2023 Jan; 102(1):45-53. PubMed ID: 36534145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
    Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
    Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The road to treating chronic active Epstein-Barr viral infection].
    Arai A
    Rinsho Ketsueki; 2021; 62(7):835-845. PubMed ID: 34349069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.
    Shibata S; Takiuchi Y; Kawasaki N; Okamoto Y; Inano S; Fukunaga A; Tabata S; Arai A; Imadome KI; Kitano T
    Int J Hematol; 2022 Apr; 115(4):595-599. PubMed ID: 35001347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: A Case of Epstein-Barr Virus-Associated Acute Liver Failure Requiring Hematopoietic Cell Transplantation After Emergent Liver Transplantation.
    Nakajima K; Hiejima E; Nihira H; Kato K; Honda Y; Izawa K; Kawabata N; Kato I; Ogawa E; Sonoda M; Okamoto T; Okajima H; Yasumi T; Takita J
    Front Immunol; 2022; 13():825806. PubMed ID: 35154146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.